Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
How the MAHA movement influenced food and beverage brands in 2025
The MAHA movement has come to stand for different things in different people’s eyes, depending on which initiatives they most closely follow.
Why Georgia-Pacific is turning its programmatic scrutinty to the sell side
The company is turning its attention to the sell side, zeroing in on the ad tech firms that move inventory for publishers — the supply-side platforms.
Future of Marketing Briefing: Why ‘just good enough’ is generative AI’s real threat to marketers
When characters and mascots are allowed to live inside generative systems, they stop being event-based and start becoming environmental.